Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director, 10%+ Owner
-
Stock Symbol
-
VERV on Nasdaq
Krishna Yeshwant - trading volume in the past year for Verve Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
6.11M |
$61.1M |
$10.00 |
Dec 1, 2023 |
By GV 2017 L.P. |
|
|
Common Stock |
4.26M |
$42.6M |
$10.00 |
Dec 1, 2023 |
By GV 2019 L.P. |
|
|
Common Stock |
1.8M |
$18M |
$10.00 |
Dec 1, 2023 |
By GV 2023, L.P. |
|
|
Stock Option (right to buy) |
136K |
|
|
Jun 26, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.